Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.

Boston Immune Technologies & Therapeutics is a clinical-stage biotechnology company developing a novel class of antagonist antibodies

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

Elligo Health Research is a healthcare-enabling research organization that integrates clinical trials directly into routine patient care

Kymera Therapeutics, Inc. is a clinical-stage biotechnology company pioneering targeted protein degradation. IPO in August 2020 (NASDAQ: KYMR).

Provider of patient experience platform designed to facilitate the relationship between physicians and patients. Acquired by NextGen 2019

Developer of staffing, communication and schedule management tools designed to modernize staffing processes. Acquired by HealthStream 2020

Perfuse Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class therapies to improve retinal blood flow and treat ischemia-driven eye diseases.

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

Qpex Biopharma is a clinical-stage biopharmaceutical company developing novel anti-infective therapies. Acquired by Shionogi 2023

Ribometrix is a biotechnology company pioneering a new class of small-molecule therapeutics that directly target the three-dimensional structures of RNA to modulate disease biology.

Rodin Therapeutics was a biotechnology company focused on discovering and developing first-in-class small molecule therapeutics. Acquired by ALKS in Nov 2019

Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023

Trefoil Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to restore vision for people with corneal diseases.
